These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9458531)

  • 21. Venous access ports: frequency and management of complications in oncology patients.
    Jordan K; Behlendorf T; Surov A; Kegel T; Maher G; Wolf HH
    Onkologie; 2008 Jul; 31(7):404-10. PubMed ID: 18596390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular access for intravenous chemotherapy: totally implanted systems.
    Meurette J; Depadt G; Meynadier J
    Eur J Surg Oncol; 1985 Sep; 11(3):295-8. PubMed ID: 4029413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in venous access devices and nursing management strategies.
    Wickham RS
    Nurs Clin North Am; 1990 Jun; 25(2):345-64. PubMed ID: 2110664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost effectiveness of different central venous approaches for port placement and use in adult oncology patients: evidence from a randomized three-arm trial.
    Biffi R; Pozzi S; Bonomo G; Della Vigna P; Monfardini L; Radice D; Rotmensz N; Zampino MG; Fazio N; Orsi F
    Ann Surg Oncol; 2014 Nov; 21(12):3725-31. PubMed ID: 24841352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of vascular access ports in femoral veins of dogs and cats with cancer.
    Cahalane AK; Rassnick KM; Flanders JA
    J Am Vet Med Assoc; 2007 Nov; 231(9):1354-60. PubMed ID: 17975994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Venous access devices in oncology].
    Maňásek V; Soumarová R; Kociánová I; Maňásková M
    Klin Onkol; 2012; 25(1):9-16. PubMed ID: 22348215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Feasibility of using the Multinational Association of Supportive Care in Cancer Antiemesis Tool for assessment of chemotherapy-induced nausea and vomiting at the Tom Baker Cancer Centre.
    Warr JK; Chambers CR; Cusano FL; Cuthbert CA; Mah MS
    J Oncol Pharm Pract; 2015 Oct; 21(5):348-57. PubMed ID: 24938292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous access devices for supportive care of patients with cancer.
    Reed WP
    Curr Opin Oncol; 1991 Aug; 3(4):634-42. PubMed ID: 1932221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Totally implantable central venous access ports. Analysis of 700 cases.
    Barbetakis N; Asteriou C; Kleontas A; Tsilikas C
    J Surg Oncol; 2011 Nov; 104(6):654-6. PubMed ID: 21671465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the introduction of the Groshong central venous catheter into the oncology/haematology department of a district general hospital.
    Todd J
    Eur J Cancer Care (Engl); 1997 Sep; 6(3):215-21. PubMed ID: 9335673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Totally implantable central venous access devices in adult oncological patients.
    Florio G; Del Papa M; Mari A; Carnì D
    Chir Ital; 2008; 60(5):697-702. PubMed ID: 19062492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maintaining vascular access devices: the nurse's role.
    Dougherty L
    Support Care Cancer; 1998 Jan; 6(1):23-30. PubMed ID: 9458533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular access devices: meeting patients' needs.
    Hadaway LC
    Medsurg Nurs; 1999 Oct; 8(5):296-303. PubMed ID: 10661167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term management of the tunneled venous catheter.
    Liangos O; Gul A; Madias NE; Jaber BL
    Semin Dial; 2006; 19(2):158-64. PubMed ID: 16551295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ESPEN Guidelines on Parenteral Nutrition: central venous catheters (access, care, diagnosis and therapy of complications).
    Pittiruti M; Hamilton H; Biffi R; MacFie J; Pertkiewicz M;
    Clin Nutr; 2009 Aug; 28(4):365-77. PubMed ID: 19464090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subcutaneous portacath utilization in pediatric oncology patients: Ramathibodi Hospital experience.
    Panthangkool W; Singhapakdi S; Teeraratkul S; Molagool S; Pakakasama S; Hathirat P; Hongeng S
    J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S77-81. PubMed ID: 10730523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ethical and legal obligation to avoid long-term tunneled catheter access.
    Rehman R; Schmidt RJ; Moss AH
    Clin J Am Soc Nephrol; 2009 Feb; 4(2):456-60. PubMed ID: 19158368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Long-term intravenous devices, continuity of care from the specialist doctor to the nurse].
    Kriegel I; Wintz L; Dupont C; Nicodème M; Fromantin I
    Soins; 2016 Nov; 61(810):14-21. PubMed ID: 27894472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Bloodstream infections of the intravascular access devices - case reports and review of the literature].
    Sochor M; Pelikánová Z; Sercl M; Mellanová V; Lazarov PP; Fáčková D
    Klin Onkol; 2012; 25(5):375-81. PubMed ID: 23102200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.